×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GPCR – structure therapeutics inc. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GPCR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
09:09 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/17
08:40 am
gpcr
Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity [Yahoo! Finance]
Low
Report
Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity [Yahoo! Finance]
12/17
08:30 am
gpcr
Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
Low
Report
Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
12/12
10:02 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/12
08:06 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its price target raised by analysts at Citizens Jmp from $87.00 to $120.00. They now have a "market outperform" rating on the stock.
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its price target raised by analysts at Citizens Jmp from $87.00 to $120.00. They now have a "market outperform" rating on the stock.
12/12
07:12 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
12/11
04:14 pm
gpcr
Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional ADSs [Yahoo! Finance]
Low
Report
Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional ADSs [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/10
05:07 pm
gpcr
Form 8-K Structure Therapeutics For: Dec 09
Low
Report
Form 8-K Structure Therapeutics For: Dec 09
12/10
05:04 pm
gpcr
Form 424B5 Structure Therapeutics
Low
Report
Form 424B5 Structure Therapeutics
12/10
02:07 pm
gpcr
Form 4 Structure Therapeutics For: Dec 08 Filed by: FMR LLC
Low
Report
Form 4 Structure Therapeutics For: Dec 08 Filed by: FMR LLC
12/8
05:28 pm
gpcr
Form 424B5 Structure Therapeutics
Low
Report
Form 424B5 Structure Therapeutics
12/8
08:47 am
gpcr
Form 8-K Structure Therapeutics For: Dec 08
High
Report
Form 8-K Structure Therapeutics For: Dec 08
11/14
12:07 pm
gpcr
Form SCHEDULE 13G/A Structure Therapeutics Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G/A Structure Therapeutics Filed by: JANUS HENDERSON GROUP PLC
11/14
09:02 am
gpcr
Form SCHEDULE 13G Structure Therapeutics Filed by: Avoro Capital Advisors LLC
Medium
Report
Form SCHEDULE 13G Structure Therapeutics Filed by: Avoro Capital Advisors LLC
11/14
08:15 am
gpcr
Form SCHEDULE 13G/A Structure Therapeutics Filed by: Deep Track Capital, LP
Medium
Report
Form SCHEDULE 13G/A Structure Therapeutics Filed by: Deep Track Capital, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: